Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology Annual Meeting Life Science Investing
Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million Life Science Investing
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting Life Science Investing
Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting Life Science Investing
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results Life Science Investing
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights Life Science Investing
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024 Life Science Investing
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635 Life Science Investing
